# RELEUKO

NDC: 70121-1571
Generic name: Filgrastim
Labeler / Manufacturer: Amneal Pharmaceuticals LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS, SUBCUTANEOUS
Marketing started: 20220225

FDA application: BLA761082

## Active ingredients

- FILGRASTIM: 480 ug/1.6mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70121-1571"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70121-1571
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=74e1ec6e-1630-4654-895c-2bd355f939e7